Content
Educational summary
Intravenous (IV) ketamine has been studied for rapid antidepressant effects in research settings. Public summaries describe evolving evidence, monitoring practices, and questions that remain under investigation.
Use this overview to prepare questions about the evidence, monitoring, logistics, and alternatives for a clinical conversation.
How pathways are generally discussed
Clinic-based infusion pathways, when offered, are typically discussed in the context of comprehensive psychiatric evaluation, safety screening, and monitored administration. Practices and protocols vary.
Questions for clinical discussion
People often ask about evidence, monitoring, alternatives, logistics, and how ketamine relates to other mood-care options. A clinician can address those questions in the context of your history.